Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 12.5788 | 99 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 12.7472 | 99 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 12.8402 | 99 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 13.0372 | 99 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 12.7558 | 99 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 12.3502 | 99 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 12.2398 | 99 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 12.6416 | 99 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 12.7247 | 99 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 12.8611 | 99 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 12.5336 | 99 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 12.8193 | 99 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 12.6489 | 99 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 12.6484 | 99 |